A new study quantifies for the first time how quickly rapid advancements in genomics may benefit patients. The research includes a five-year review of more than 300 epilepsy cases that showed about a third of children had a change in diagnosis based on new data. In some cases, the review helped doctors prescribe a more effective treatment.